Collegium Pharmaceutical, Inc. COLL
NASDAQ · United States · Health Technology
$21.82-0.41 (-1.84%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 1.92 | 1.72 | +11.7% | $199.88M | +0.1% | -17.5%$35.74→$29.47 |
| Q1 2026 | 2026-05-07 | 1.50 | 1.23 | +22.0% | — | — | +3.5%$36.51→$37.80 |
| Q4 2025 | 2026-02-26 | 1.85 | 2.01 | -8.0% | — | — | -8.9%$45.75→$41.67 |
| Q3 2025 | 2025-11-06 | 2.06 | 1.69 | +21.9% | — | — | +18.0%$35.85→$42.30 |
| Q4 2023 | 2024-02-22 | 1.58 | 1.25 | +26.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.